International Journal of Hematology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)
Int J Hematol. 2024 Mar 14. doi: 10.1007/s12185-024-03730-2. Online ahead of print.NO ABSTRACTPMID:38483689 | DOI:10.1007/s12185-024-03730-2 (Source: International Journal of Hematology)
Source: International Journal of Hematology - March 14, 2024 Category: Hematology Authors: Yoshinobu Maeda Source Type: research

Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study
Int J Hematol. 2024 Mar 9. doi: 10.1007/s12185-024-03745-9. Online ahead of print.ABSTRACTThe dosage of chemotherapy drugs for overweight/obese children with acute myeloid leukemia (AML) has been empirically reduced based on ideal body weight (BW) in Japan to reduce the risk of adverse events. We investigated the associations between pre-therapeutic body mass index (BMI) and clinical outcomes among children with AML. A total of 280 children were divided into two groups based on the World Health Organization Child Growth Standards: a healthy-weight group (n = 254), and an overweight/obese group (n = 26). If BW exceeded 1.2 ...
Source: International Journal of Hematology - March 9, 2024 Category: Hematology Authors: Hirozumi Sano Keitaro Fukushima Michihiro Yano Shinya Osone Yoko Kato Daiichiro Hasegawa Takako Miyamura Shotaro Iwamoto Hiroyuki Takahashi Kiminori Terui Akio Tawa Daisuke Tomizawa Source Type: research

Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan
Int J Hematol. 2024 Mar 8. doi: 10.1007/s12185-024-03740-0. Online ahead of print.ABSTRACTMyeloid and lymphoid neoplasms associated with FGFR1 abnormalities (MLN-FGFR1 abnormalities) are rare hematologic malignancies associated with chromosome 8p11.2 abnormalities. Translocations of 8p11.2 were detected in 10 of 17,039 (0.06%) unique patient cytogenetic studies performed at nine institutions in Japan. No inversions or insertions of 8p11.2 were detected. Among the 10 patients with 8p11.2 translocations, three patients were diagnosed with MLN-FGFR1 abnormalities, which were confirmed by FISH analysis. Peripheral blood eosino...
Source: International Journal of Hematology - March 8, 2024 Category: Hematology Authors: Kensuke Usuki Takuro Kameda Noriaki Kawano Tomoki Ito Yoshinori Hashimoto Kotaro Shide Hiroshi Kawano Masaaki Sekine Takanori Toyama Hiromitsu Iizuka Seiichi Sato Masanori Takeuchi Junzo Ishizaki Kouichi Maeda Michikazu Nakai Kiyoshi Yamashita Yoko Kubuki Source Type: research

Numerous osteoclasts and osteoblasts in the bone marrow due to hyperparathyroidism
Int J Hematol. 2024 Mar 6. doi: 10.1007/s12185-024-03742-y. Online ahead of print.NO ABSTRACTPMID:38446380 | DOI:10.1007/s12185-024-03742-y (Source: International Journal of Hematology)
Source: International Journal of Hematology - March 6, 2024 Category: Hematology Authors: Yi Feng Tao Wang Source Type: research

Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study
Int J Hematol. 2024 Mar 6. doi: 10.1007/s12185-024-03739-7. Online ahead of print.NO ABSTRACTPMID:38446381 | DOI:10.1007/s12185-024-03739-7 (Source: International Journal of Hematology)
Source: International Journal of Hematology - March 6, 2024 Category: Hematology Authors: Norio Komatsu Kojo Arita Hironori Mitsui Takanori Nemoto Koji Hanaki Source Type: research

Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia
CONCLUSION: ETV6::ABL1 is a rare but recurrent genetic aberration in AML, and the combined use of fluorescence in situ hybridization and PCR can better identify this fusion gene. Patients carrying ETV6::ABL1 have a high relapse rate and a poor prognosis. TKIs are a reasonable treatment option for this group, and allo-HSCT may be curative.PMID:38441775 | DOI:10.1007/s12185-024-03729-9 (Source: International Journal of Hematology)
Source: International Journal of Hematology - March 5, 2024 Category: Hematology Authors: Song Xue Hui-Peng Sun Xiao-Bing Huang Xue Chen Tong Wang Wei Ma Yao Tian Zhi-Lan Pan Li-Hong Li Lu Zhang Hong-Xing Liu Xing-Yu Cao Source Type: research

Decade-long WT1-specific CTLs induced by WT1 peptide vaccination
CONCLUSION: The WT1 peptide vaccine induced an immune response that persists for more than 10 years, even after cessation of vaccination in the CML patient.PMID:38427208 | DOI:10.1007/s12185-024-03723-1 (Source: International Journal of Hematology)
Source: International Journal of Hematology - March 1, 2024 Category: Hematology Authors: Tatsuya Suwabe Yasuhiko Shibasaki Suguru Tamura Takayuki Katagiri Kyoko Fuse Tori Ida-Kurasaki Takashi Ushiki Hirohito Sone Miwako Narita Masayoshi Masuko Source Type: research